πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 32 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12383522

Baclofen formulations and methods of minimizing patient exposure to metabolite variations

AMNEAL PHARMACEUTICALS LLC Β· Granted Tue Aug 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12370163

Levodopa dosing regimen

AMNEAL PHARMACEUTICALS LLC Β· Granted Tue Jul 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12303482

Levodopa dosing regimen

AMNEAL PHARMACEUTICALS LLC Β· Granted Tue May 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12303481

Levodopa dosing regimen

AMNEAL PHARMACEUTICALS LLC Β· Granted Tue May 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12295931

Levodopa dosing regimen

AMNEAL PHARMACEUTICALS LLC Β· Granted Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12263148

Levodopa dosing regimen

AMNEAL PHARMACEUTICALS LLC Β· Granted Tue Apr 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12263149

Levodopa dosing regimen

AMNEAL PHARMACEUTICALS LLC Β· Granted Tue Apr 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12233166

Extended release compositions comprising pyridostigmine

Amneal Complex Products Research LLC Β· Granted Tue Feb 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12201596

Levodopa dosing regimen

AMNEAL PHARMACEUTICALS LLC Β· Granted Tue Jan 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12194150

Levodopa dosing regimen

AMNEAL PHARMACEUTICALS LLC Β· Granted Tue Jan 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12109185

Levodopa dosing regimen

AMNEAL PHARMACEUTICALS LLC Β· Granted Tue Oct 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12011502

Compositions and methods of administering baclofen

AMNEAL PHARMACEUTICALS LLC Β· Granted Tue Jun 18 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11986449

Levodopa dosing regimen

AMNEAL PHARMACEUTICALS LLC Β· Granted Tue May 21 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 16 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11931328

Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives

AMNEAL PHARMACEUTICALS LLC Β· Granted Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11911515

Extended release compositions comprising pyridostigmine

Amneal Complex Products Research LLC Β· Granted Tue Feb 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11850225

Baclofen formulations and methods of minimizing patient exposure to metabolite variations

AMNEAL PHARMACEUTICALS LLC Β· Granted Tue Dec 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11666536

Extended release compositions comprising pyridostigmine

Amneal Complex Products Research LLC Β· Granted Tue Jun 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11654124

Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives

AMNEAL PHARMACEUTICALS LLC Β· Granted Tue May 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11564888

Extended release compositions comprising trihexyphenidyl

Amneal Complex Products Research LLC Β· Granted Tue Jan 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11547670

Delayed release methylphenidate compositions

Amneal Complex Products Research LLC Β· Granted Tue Jan 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11523984

Compositions and methods of administering baclofen

AMNEAL PHARMACEUTICALS LLC Β· Granted Tue Dec 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11491125

Baclofen formulations and methods of minimizing patient exposure to metabolite variations

AMNEAL PHARMACEUTICALS LLC Β· Granted Tue Nov 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11478425

Extended release compositions comprising pyridostigmine

Amneal Complex Products Research LLC Β· Granted Tue Oct 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11439585

Programmable pharmaceutical compositions for chrono drug release

Amneal Complex Products Research LLC Β· Granted Tue Sep 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted